Vaccination

US funding sees Covid-19 antibody trial enter next phase

UK pharmaceuticals group AstraZeneca said on Monday it will advance trials of a Covid-19 treatment to a crucial third stage, after the United States invested $486 million (411 million euros) in its development.

Diseases, Conditions, Syndromes

Chinese coronavirus vaccine approved for military use

China's military has approved a coronavirus vaccine for use within its ranks that has been developed by its research unit and a biotech firm, the company said Monday.

Diseases, Conditions, Syndromes

Fall in new cases raises hope in virus outbreak in China

The number of new cases of the coronavirus in China dropped for a second straight day, health officials said Wednesday in a possible glimmer of hope amid the outbreak that has infected over 45,000 people worldwide and killed ...

Diseases, Conditions, Syndromes

Companies look into possible vaccines for China virus

Clinical trials for a vaccine against the new virus sweeping China could be carried out in the summer, the head of an anti-epidemic coalition said on Thursday, as different companies announced research into the disease.

Medications

Reckitt pays US $1.4bn to settle opioid treatment spat

British consumer health giant Reckitt Benckiser announced Thursday it will pay up to $1.4 billion (1.2 billion euros) to settle a dispute with US authorities over the sale and marketing of an opioid addiction treatment.

Health

A look at where companies stand on marijuana business

When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry—and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, ...

page 2 from 4